RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
151 hedge funds and large institutions have $704M invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2021 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 49 increasing their positions, 49 reducing their positions, and 62 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
74% less capital invested
Capital invested by funds: $2.69B → $704M (-$1.98B)
Holders
151
Holding in Top 10
1
Calls
$18.7M
Puts
$13.6M
Top Buyers
| 1 | +$26.5M | |
| 2 | +$15.9M | |
| 3 | +$8.7M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
+$8.51M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$6.86M |
Top Sellers
| 1 | -$68.9M | |
| 2 | -$30.5M | |
| 3 | -$15.8M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$15.5M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$11.6M |